BRIEF-Biogen completes submission of new drug application By: Reuters: Company News September 26, 2016 at 07:45 AM EDT * Biogen completes rolling submission of new drug application to FDA for nusinersen as a treatment for spinal muscular atrophy Read More >> Related Stocks: Biogen Idec Ionis Pharmaceuticals